SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Sormani Maria Pia)
 

Search: WFRF:(Sormani Maria Pia) > Neurofilaments as b...

Neurofilaments as biomarkers in neurological disorders - towards clinical application.

Khalil, Michael (author)
Teunissen, Charlotte E (author)
Lehmann, Sylvain (author)
show more...
Otto, Markus (author)
Piehl, Fredrik (author)
Ziemssen, Tjalf (author)
Bittner, Stefan (author)
Sormani, Maria Pia (author)
Gattringer, Thomas (author)
Abu-Rumeileh, Samir (author)
Thebault, Simon (author)
Abdelhak, Ahmed (author)
Green, Ari (author)
Benkert, Pascal (author)
Kappos, Ludwig (author)
Comabella, Manuel (author)
Tumani, Hayrettin (author)
Freedman, Mark S (author)
Petzold, Axel (author)
Blennow, Kaj, 1958 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Zetterberg, Henrik, 1973 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Leppert, David (author)
Kuhle, Jens (author)
show less...
 (creator_code:org_t)
2024
2024
English.
In: Nature Reviews Neurology. - 1759-4758 .- 1759-4766. ; 20:5, s. 269-287
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Neurofilament proteins have been validated as specific body fluid biomarkers of neuro-axonal injury. The advent of highly sensitive analytical platforms that enable reliable quantification of neurofilaments in blood samples and simplify longitudinal follow-up has paved the way for the development of neurofilaments as a biomarker in clinical practice. Potential applications include assessment of disease activity, monitoring of treatment responses, and determining prognosis in many acute and chronic neurological disorders as well as their use as an outcome measure in trials of novel therapies. Progress has now moved the measurement of neurofilaments to the doorstep of routine clinical practice for the evaluation of individuals. In this Review, we first outline current knowledge on the structure and function of neurofilaments. We then discuss analytical and statistical approaches and challenges in determining neurofilament levels in different clinical contexts and assess the implications of neurofilament light chain (NfL) levels in normal ageing and the confounding factors that need to be considered when interpreting NfL measures. In addition, we summarize the current value and potential clinical applications of neurofilaments as a biomarker of neuro-axonal damage in a range of neurological disorders, including multiple sclerosis, Alzheimer disease, frontotemporal dementia, amyotrophic lateral sclerosis, stroke and cerebrovascular disease, traumatic brain injury, and Parkinson disease. We also consider the steps needed to complete the translation of neurofilaments from the laboratory to the management of neurological diseases in clinical practice.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Keyword

Humans
Biomarkers
metabolism
blood
Nervous System Diseases
diagnosis
metabolism
blood
Neurofilament Proteins
blood
Intermediate Filaments
metabolism

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view